Literature DB >> 18505340

Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers.

E Cetin1, B Cengiz, E Gunduz, M Gunduz, H Nagatsuka, L Bekir-Beder, K Fukushima, D Pehlivan, M Ozaslan N, K Nishizaki, K Shimizu, N Nagai.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a diverse group of cancers that are frequently aggressive in their biologic behavior. Inactivation of tumor suppressor gene (TSG) is one of the most critical steps leading to HNSCC. Loss of heterozygosity analysis is very sensitive method for the detection of frequent allelic loss in a chromosomal locus. This method has been considered as an important evidence for the localization of TSGs. We analyzed loss of heterozygosity (LOH) at chromosome 4q22-35 region by using 14 polymorphic microsatellite markers in 83 matched normal and HNSCC tissues. LOH was detected at least in one location in 71 of 83 (86%) tumor tissues. Frequent deletions were detected at the location of microsatellite markers, D4S2909 (46%), D4S2623 (51%), D4S406 (48%), D4S1644 (45%) and D4S2979 (40%). Four different frequently deleted regions at 4q22, 4q25, 4q31 and 4q34-35 were observed. These regions include several putative TSGs such as Caspase-6, SMARCAD1, SMARCA5, SAP30 and ING2. Further molecular analysis of each gene should be performed to clarify their roles in head and neck squamous cell carcinogenesis.

Entities:  

Mesh:

Year:  2008        PMID: 18505340

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  10 in total

1.  Replacement of the myotonic dystrophy type 1 CTG repeat with 'non-CTG repeat' insertions in specific tissues.

Authors:  Michelle M Axford; Arturo López-Castel; Masayuki Nakamori; Charles A Thornton; Christopher E Pearson
Journal:  J Med Genet       Date:  2011-05-27       Impact factor: 6.318

2.  Primary intestinal lymphangiectasia diagnosed by capsule endoscopy and double balloon enteroscopy.

Authors:  Tak Geun Oh; Joo Won Chung; Hee Man Kim; Seok-Joo Han; Jin Sung Lee; Jung Yeob Park; Si Young Song
Journal:  World J Gastrointest Endosc       Date:  2011-11-16

Review 3.  Inhibitor of growth tumor suppressors in cancer progression.

Authors:  Brad Piche; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-03-02       Impact factor: 9.261

4.  Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.

Authors:  Marianne Berg; Trude H Agesen; Espen Thiis-Evensen; Marianne A Merok; Manuel R Teixeira; Morten H Vatn; Arild Nesbakken; Rolf I Skotheim; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2010-05-06       Impact factor: 27.401

5.  Identification of novel germline polymorphisms governing capecitabine sensitivity.

Authors:  Peter H O'Donnell; Amy L Stark; Eric R Gamazon; Heather E Wheeler; Bridget E McIlwee; Lidija Gorsic; Hae Kyung Im; R Stephanie Huang; Nancy J Cox; M Eileen Dolan
Journal:  Cancer       Date:  2012-01-03       Impact factor: 6.860

Review 6.  Altered primary chromatin structures and their implications in cancer development.

Authors:  Angelo Ferraro
Journal:  Cell Oncol (Dordr)       Date:  2016-03-23       Impact factor: 6.730

7.  Deletion of chromosome 4q predicts outcome in stage II colon cancer patients.

Authors:  R P M Brosens; E J T H Belt; J C Haan; T E Buffart; B Carvalho; H Grabsch; P Quirke; M A Cuesta; A F Engel; B Ylstra; G A Meijer
Journal:  Cell Oncol (Dordr)       Date:  2011-06-30       Impact factor: 6.730

8.  Unsupervised Analysis of Array Comparative Genomic Hybridization Data from Early-Onset Colorectal Cancer Reveals Equivalence with Molecular Classification and Phenotypes.

Authors:  María Arriba; Juan L García; Daniel Rueda; Jessica Pérez; Lorena Brandariz; Oana A Nutu; Laura Alonso; Yolanda Rodríguez; Miguel Urioste; Rogelio González-Sarmiento; José Perea
Journal:  Neoplasia       Date:  2016-12-15       Impact factor: 5.715

Review 9.  Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer.

Authors:  Alice Blondel; Amine Benberghout; Rémy Pedeux; Charles Ricordel
Journal:  Cancers (Basel)       Date:  2019-10-21       Impact factor: 6.639

10.  Loss of smarcad1a accelerates tumorigenesis of malignant peripheral nerve sheath tumors in zebrafish.

Authors:  Han Han; Guangzhen Jiang; Rashmi Kumari; Martin R Silic; Jake L Owens; Chang-Deng Hu; Suresh K Mittal; GuangJun Zhang
Journal:  Genes Chromosomes Cancer       Date:  2021-08-07       Impact factor: 4.263

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.